Skip to content

A study for evaluating the influence on a viability of lactic acid bacteria in intestinal tract due to the difference of form. A randomized, single-blind trial.

A study for evaluating the influence on a viability of lactic acid bacteria in intestinal tract due to the difference of form. A randomized, single-blind trial. - A study for evaluating the influence on a viability of lactic acid bacteria in intestinal tract due to the difference of form.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024070
Enrollment
16
Registered
2016-09-16
Start date
2016-09-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Lactic acid bacteria powder Chocolate containing lactic acid bacteria

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Males and females from 20 to 64 years of age (2) Subjects who have a daily bowel movement (3) Subjects giving written informed consent

Exclusion criteria

Exclusion criteria: (1) Individuals with a loose stool and/or a tendency for constipation Individuals taking in common use (2) Individuals taking antiflatulents and/or laxatives (including purgative drug) and/or health foods in common use, including food for specified health use (3) Individuals taking antibiotics and/or drugs which influence laxatives(including purgative drugs) in common use (4) Individuals who are not able to stop consumption of foods containing lactic acid bacteria, bifidobacteria, natto bacteria, oligosaccharides, dietary fibers, high amount of sugar alcohol and/or other health foods including food for specified health use, which influence intestinal regulation during the study period (5) Individuals presenting known food allergy (6) Individuals taking large amounts of alcohol on a daily basis (7) Individuals who are suffered from a disease which needs treatment urgently or individuals with severe complications (8) Individuals with a digestive organ disease or surgical history who has an influence on digestive absorption and defecation (9) Individuals who are under treatment or have a history of irritable bowel syndrome (10) Individuals who are judged to be unsuitable as a subject from an answer of a subjective background questionnaire (11) Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period (12) Individuals who are under treatment or have a history of drug/alcohol dependence (13) Individuals who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics (14) Individuals who are judged as unsuitable for the study by the investigator for the other reasons

Design outcomes

Primary

MeasureTime frame
Number of viable Lactobacillus brevis in the feces

Secondary

MeasureTime frame
Number of subjects detected viable Lactobacillus brevis in the feces after ingestion of test food

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Corporation Sales department

yoshikawa@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026